Hafez, G. Et Al. 2023. Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients. CLINICAL KIDNEY JOURNAL , no.12 , 2378-2392.

Hafez, G., Malyszko, J., Golenia, A., Klimkowicz-Mrowiec, A., Ferreira, A. C., ARICI, M., ... Bruchfeld, A.(2023). Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients. CLINICAL KIDNEY JOURNAL , no.12, 2378-2392.

Hafez, Gaye Et Al. "Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients," CLINICAL KIDNEY JOURNAL , no.12, 2378-2392, 2023

Hafez, Gaye Et Al. "Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients." CLINICAL KIDNEY JOURNAL , no.12, pp.2378-2392, 2023

Hafez, G. Et Al. (2023) . "Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients." CLINICAL KIDNEY JOURNAL , no.12, pp.2378-2392.

@article{article, author={Gaye Hafez Et Al. }, title={Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients}, journal={CLINICAL KIDNEY JOURNAL}, year=2023, pages={2378-2392} }